Interim safety and efficacy results of a phase II clinical trial on trametinib and low-dose dabrafenib in patients with advanced BRAFV600 wild-type melanoma

Gil Awada, Julia Katharina Schwarze, Eva Reijmen, Cleo Goyvaerts, Giuseppe Fasolino, Sandrine Aspeslagh, Bart Neyns

Research output: Contribution to journal › Meeting abstract (Journal)

104 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Interim safety and efficacy results of a phase II clinical trial on trametinib and low-dose dabrafenib in patients with advanced BRAFV600 wild-type melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences